Fate Therapeutics (FATE) Interest Coverage Ratio Growth (1y) (2014 - 2019)
Fate Therapeutics (FATE) Interest Coverage Ratio Growth (1y) (2014 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Fate Therapeutics |
250.86 Mn |
250.86 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2019 |
-24.48% |
| Sep 30, 2019 |
-74.25% |
| Jun 30, 2019 |
-30.52% |
| Mar 31, 2019 |
-48.00% |
| Dec 31, 2018 |
-31.00% |
| Sep 30, 2018 |
-42.24% |
| Jun 30, 2018 |
-2.19% |
| Mar 31, 2018 |
9.00% |
| Dec 31, 2017 |
-27.74% |
| Sep 30, 2017 |
-25.54% |
| Jun 30, 2017 |
-145.33% |
| Mar 31, 2017 |
-136.77% |
| Dec 31, 2016 |
-80.74% |
| Sep 30, 2016 |
-106.60% |
| Jun 30, 2016 |
-43.52% |
| Mar 31, 2016 |
-20.62% |
| Dec 31, 2015 |
47.59% |
| Sep 30, 2015 |
67.04% |
| Jun 30, 2015 |
94.06% |
| Mar 31, 2015 |
91.86% |
